Work

First-In-Human Phase I Trial Assessing the Highly Selective C-Met Inhibitor Msc2156119J (Emd 1214063) in Patients with Advanced Solid Tumors

Year: 2014

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu331.10

Authors: G.S. Falchook, D.S. Hong, H.M. Amin, S. Fu, S.A. Piha-Paul, F. Janku, H. Zheng, F. Bladt, A. Johne, R. Kurzrock

Institutions: The University of Texas MD Anderson Cancer Center, EMD Serono, Inc. (United States), Merck Healthcare KGaA, Darmstadt (Germany), Merck KGaA, Darmstadt (Germany), University of California San Diego, Moores Cancer Center

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2261334879

FWCI:

Cites:

Cited by: 1

Related to: 10